Ayahuasca ceremony leaders' perspectives on special considerations for eating disorders
This qualitative study (n=15) explores the perspectives of ayahuasca ceremony leaders, primarily from the West/Global North, on the suitability of ceremonial ayahuasca use for individuals with eating disorders (EDs). The analysis identifies categories such as screening for EDs, purging and dietary restrictions, potential risks, and complementarity with conventional ED treatment. The findings suggest the need for careful screening and extra support to ensure safe and beneficial ayahuasca ceremony experiences for individuals with EDs.
Authors
- Adele Lafrance
- Martin Williams
Published
Abstract
Eating disorders (EDs) are difficult conditions to resolve, necessitating novel treatments. Ayahuasca, a psychedelic plant medicine originating in Indigenous Amazonian communities, is being investigated. Aspects of ceremonial ayahuasca use (purging, dietary restrictions) appear similar to ED behaviors, raising questions about ayahuasca’s suitability as an intervention for individuals with EDs. This study explored the perspectives of ayahuasca ceremony leaders on these and other considerations for ceremonial ayahuasca drinking among individuals with EDs. A qualitative content analysis of interviews was undertaken with 15 ayahuasca ceremony leaders, the majority of whom were from the West/Global North. Screening for EDs, purging and dietary restrictions, potential risks and dangers, and complementarity with conventional ED treatment emerged as categories. The findings offer ideas, including careful screening and extra support, to promote safe and beneficial ceremony experiences for ceremony participants with EDs. More research is needed to clarify the impacts of ceremony-related purging and preparatory diets. To evolve conventional models of treatment, the ED field could consider Indigenous approaches to mental health whereby ayahuasca ceremony leaders and ED researchers and clinicians collaborate in a decolonizing, bidirectional bridging process between Western and Indigenous paradigms of healing.
Research Summary of 'Ayahuasca ceremony leaders' perspectives on special considerations for eating disorders'
Introduction
Eating disorders (EDs) are complex, often chronic conditions with high relapse and treatment dropout rates, motivating investigation of novel therapies. Recent psychedelic research has included trials of psilocybin and MDMA for ED-related conditions, and ayahuasca—a traditional Amazonian brew containing DMT plus MAOIs—has drawn interest because its acute effects (including vivid imagery, strong emotions and somatic phenomena such as vomiting) and ceremonial practices (notably preparatory dietary restrictions and in‑ceremony purging) overlap in some respects with behaviours and rituals familiar in EDs. These overlaps raise specific questions about safety, suitability, and the meaning of such experiences for people with EDs. Williams and colleagues set out to explore these questions from the viewpoint of ayahuasca ceremony leaders. The study aimed to characterise leaders' experiences and beliefs about screening, risks, behavioural overlap (purging and diets), and potential complementarities between ceremonial ayahuasca use and conventional ED treatments, with a view to informing safer participation and future research directions.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topic
- Authors
- APA Citation
Williams, M., Kingston Miller, A., & Lafrance, A. (2024). Ayahuasca ceremony leaders' perspectives on special considerations for eating disorders. Eating Disorders, 32(2), 120-139. https://doi.org/10.1080/10640266.2023.2271201
References (23)
Papers cited by this study that are also in Blossom
Bouso, J. C., Andión, O., Sarris, J. et al. · PLOS Global Public Health (2022)
Brewerton, T. D., Wang, J. B., Lafrance, A. et al. · Journal of Psychiatric Research (2022)
Callon, C., Williams, M., Lafrance, A. · Journal of Humanistic Psychology (2021)
Carhart-Harris, R. L., Kaelen, M., Whalley, M. G. et al. · Psychopharmacology (2014)
Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)
Domínguez-Clavé, E., Soler, J., Elices, M. et al. · Brain Research Bulletin (2016)
Dos Santos, R. G., Balthazar, F. M., Bouso, J. C. et al. · Journal of Psychopharmacology (2016)
Dos Santos, R. G., Hallak, J. E., Bouso, J. C. · Therapeutic Advances in Psychopharmacology (2017)
Santos, R. G., Landeira-Fernandez, J., Strassman, R. J. et al. · Journal of Ethnopharmacology (2007)
Dupuis, D. · Transcultural Psychiatry (2021)
Show all 23 referencesShow fewer
Gómez-Sousa, M., Jiménez-Garrido, D. F., Ona, G. et al. · Journal of Clinical Psychopharmacology (2021)
Jacob, M. S., Presti, D. E. · Medical Hypotheses (2005)
Kometer, M., Vollenweider, F. X. · Behavioral Neurobiology of Psychedelic Drugs (2016)
Lafrance, A., Loizaga-Velder, A., Fletcher, J. et al. · Journal of Psychoactive Drugs (2017)
Leary, T., Litwin, G. H., Metzner, R. · Journal of Nervous and Mental Disease (1977)
Loizaga-Velder, A., Verres, R. · Journal of Psychoactive Drugs (2014)
Ona, G., Berrada, A., Bouso, J. C. · Transcultural Psychiatry (2021)
O'shaughnessy, D. M., Berlowitz, I., Rodd, R. et al. · Therapeutic Advances in Psychopharmacology (2021)
Palhano-Fontes, F., Barreto, D., Onias, H. et al. · Psychological Medicine (2018)
Renelli, M., Fletcher, J., Tupper, K. W. et al. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2018)
Spriggs, M. J., Kettner, •. H., Carhart-Harris, •. R. L. · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity (2020)
Trichter, S. · Journal of Transpersonal Psychology (2010)
Araújo, D. B., Zeifman, R. J., Palhano-Fontes, F. et al. · Frontiers in Pharmacology (2019)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.